Pharmaceutical

Olanzapine ER by Teva Pharmaceutical Industries for Schizophrenia: Likelihood of Approval

Olanzapine ER is under clinical development by Teva Pharmaceutical Industries and currently in Phase III for Schizophrenia.

Jun 18, 2024 - 04:00
Olanzapine ER is under clinical development by Teva Pharmaceutical Industries and currently in Phase III for Schizophrenia.
Read the original article

Tags:

Previous Article

Omalizumab biosimilar by Teva Pharmaceutical Industries for Chronic Urticaria Or...

Next Article

MAS-825 by Novartis for Coronary Artery Disease (CAD) (Ischemic Heart Disease): ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Conservative group opposing PBM reform spends record number on lobbying

STAT+: Conservative group opposing PBM reform spends re...

Jul 18, 2023

Obesity market expected to reach $37.1bn across 7MM by 2031

Obesity market expected to reach $37.1bn across 7MM by ...

Mar 29, 2023

STAT wants to know your pick for a great summer read or listen

STAT wants to know your pick for a great summer read or...

May 31, 2023